Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Long-Term Investments (2023 - 2025)

Historic Long-Term Investments for Lexaria Bioscience (LEXX) over the last 3 years, with Q4 2025 value amounting to $64013.0.

  • Lexaria Bioscience's Long-Term Investments changed 0.16% to $64013.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $64013.0, marking a year-over-year change of 0.16%. This contributed to the annual value of $64013.0 for FY2025, which is 68.9% up from last year.
  • As of Q4 2025, Lexaria Bioscience's Long-Term Investments stood at $64013.0, which was down 0.16% from $64013.0 recorded in Q3 2025.
  • Over the past 5 years, Lexaria Bioscience's Long-Term Investments peaked at $64014.0 during Q4 2024, and registered a low of $48559.0 during Q3 2023.
  • Moreover, its 3-year median value for Long-Term Investments was $64013.0 (2025), whereas its average is $61743.1.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 3092.32% in 2024, then decreased by 0.16% in 2025.
  • Quarter analysis of 3 years shows Lexaria Bioscience's Long-Term Investments stood at $48559.0 in 2023, then soared by 31.83% to $64014.0 in 2024, then dropped by 0.0% to $64013.0 in 2025.
  • Its Long-Term Investments stands at $64013.0 for Q4 2025, versus $64013.0 for Q3 2025 and $64014.0 for Q2 2025.